Máiz, LuisNieto, RosaDuran Barata, DiegoMáiz, JoséRuiz Calvo, GabrielMuriel, AlfonsoBarbero, EstherVélez Díaz-Pallarés, ManuelMorillo, Raquel2026-05-072026-05-072025Máiz, L., Nieto, R., Durán, D., Máiz, J., Ruiz-Calvo, G., Muriel, A., Barbero, E., Vélez-Díaz-Pallarés, M., & Morillo, R. (2025). Short-term tolerance to inhaled antibiotics in patients with bronchial infection not associated with cystic fibrosis. Open Respiratory Archives, 7(3), 100460. https://doi.org/10.1016/j.opresp.2025.1004602659-6636https://hdl.handle.net/11268/17080The use of intravenous antibiotic formulations delivered by inhalation is controversial. Tolerance can be an issue and some treatment guidelines discourage this route of administration if the same antibiotic is available in an inhalation formulation. This was a retrospective, observational, single-center study comparing tolerance to three antibiotics delivered by nebulization (intravenous formulations of ampicillin and gentamicin, and an inhalation formulation of colistimethate sodium) in patients with bronchial infection (BI), chronic bronchial infection (CBI), and/or recurrent respiratory infections. The study also aimed to identify factors potentially associated with tolerability.engAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/MedicinaAntibacterianosInfecciones del Sistema RespiratorioTolerancia a Medicamentosjournal article10.1016/j.opresp.2025.100460open accessMedicamentoAparato respiratorioInvestigación médicaGoal 3: Ensure healthy lives and promote well-being for all at all ages